Phase II trial of dasatinib for patients demonstrating acquired resistance to treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) erlotinib (E) or gefitinib (G).

被引:0
|
作者
Johnson, Melissa L. [1 ]
Riely, Gregory J. [1 ]
Rizvi, Naiyer A. [1 ]
Azzoli, Christopher G. [1 ]
Kris, Mark G. [1 ]
Ginsberg, Michelle S. [1 ]
Pao, William [1 ,2 ]
Miller, Vincent A. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Vanderbilt Univ, Nashville, TN USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S687 / S687
页数:1
相关论文
共 50 条
  • [41] Histological transformation after acquired resistance to epidermal growth factor tyrosine kinase inhibitors
    Shao, Yi
    Zhong, Dian-Sheng
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (02) : 235 - 242
  • [42] Histological transformation after acquired resistance to epidermal growth factor tyrosine kinase inhibitors
    Yi Shao
    Dian-Sheng Zhong
    International Journal of Clinical Oncology, 2018, 23 : 235 - 242
  • [43] New Strategies in Overcoming Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer
    Oxnard, Geoffrey R.
    Arcila, Maria E.
    Chmielecki, Juliann
    Ladanyi, Marc
    Miller, Vincent A.
    Pao, William
    CLINICAL CANCER RESEARCH, 2011, 17 (17) : 5530 - 5537
  • [44] Acquired resistance to an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in an uncommon G719S EGFR mutation
    Atsushi Osoegawa
    Takafumi Hashimoto
    Yohei Takumi
    Miyuki Abe
    Tomonori Yamada
    Ryoji Kobayashi
    Michiyo Miyawaki
    Hideya Takeuchi
    Tatsuro Okamoto
    Kenji Sugio
    Investigational New Drugs, 2018, 36 : 999 - 1005
  • [45] Acquired resistance to an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in an uncommon G719S EGFR mutation
    Osoegawa, Atsushi
    Hashimoto, Takafumi
    Takumi, Yohei
    Abe, Miyuki
    Yamada, Tomonori
    Kobayashi, Ryoji
    Miyawaki, Michiyo
    Takeuchi, Hideya
    Okamoto, Tatsuro
    Sugio, Kenji
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (06) : 999 - 1005
  • [46] Effective assessment of low times MET amplification in pleural effusion after epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) acquired resistance Cases report
    Wang, Chang-guo
    Zeng, Da-xiong
    Huang, Jian-an
    Jiang, Jun-hong
    MEDICINE, 2018, 97 (01)
  • [47] ANALYSIS OF HER2 AMPLIFICATION IN NON-SMALL CELL LUNG CANCERS (NSCLCS) WITH ACQUIRED RESISTANCE (AR) TO EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) TYROSINE KINASE INHIBITORS (TKIS)
    Politi, Katerina
    Wurtz, Anna
    Walther, Zenta
    Cai, Guoping
    Pirazzoli, Valentina
    Melnick, Mary Ann
    Reynolds, Laura
    Boyer, Julie
    Chiang, Anne
    Morgensztern, Daniel
    Goldberg, Sarah
    Herbst, Roy
    Lynch, Thomas
    Gettinger, Scott N.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S354 - S355
  • [48] Efficacy of platinum-doublet chemotherapy for patients with lung cancer with epidermal growth factor receptor (EGFR) activating mutation after the failure of EGFR-tyrosine kinase inhibitors (TKIs) treatment
    Watanabe, S.
    Goto, Y.
    Shiraishi, H.
    Tsuruoka, K.
    Yoshida, K.
    Itahashi, K.
    Asao, T.
    Kitahara, S.
    Horinouchi, H.
    Kanda, S.
    Fujiwara, Y.
    Nokihara, H.
    Yamamoto, N.
    Ohe, Y.
    ANNALS OF ONCOLOGY, 2015, 26 : 137 - 137
  • [49] Morphologic Features of Adenocarcinoma of the Lung Predictive of Response to the Epidermal Growth Factor Receptor Kinase Inhibitors Erlotinib and Gefitinib
    Zakowski, Maureen F.
    Hussain, Sanaa
    Pao, William
    Ladanyi, Marc
    Ginsberg, Michelle S.
    Heelan, Robert
    Miller, Vincent A.
    Rusch, Valerie W.
    Kris, Mark G.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2009, 133 (03) : 470 - 477
  • [50] Neuroendocrine Differentiation in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
    Chang, Youjin
    Kim, Seon Ye
    Choi, Yun Jung
    So, Kwang Sup
    Rho, Jin Kyung
    Kim, Woo Sung
    Lee, Jae Cheol
    Chung, Jin-Haeng
    Choi, Chang-Min
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2013, 75 (03) : 95 - 103